TERAPORE TECHNOLOGIES, INC.
SOUTH SAN FRANCISCO, CA · Founded 2013 · CIK 0001678371 · Biotech · Private
Ultrafiltration membranes with self-assembling organic molecules for selective protein purification
terapore.com →- Grants
- $375K
- 2 awards
- Sector median: 1
- Raised
- $3.5M
- 2 Form D · Jan 2018
- 105 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 38
- 7 granted · 31 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Hierarchically Porous Membrane Media for Affinity-based Separations | $149,997 | |
| Federal grant | Department of Health and Human Services · Phase I · High Resolution Protein Separations via Charged Block Copolymer Membranes | $224,929 | |
| Private capital raised | Form D · SEC | $1,756,028 | |
| Private capital raised | Form D · SEC | $1,774,997 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2451 | PROTEAN BIO INC. | — | — |
| 2452 | PALM THERAPEUTICS, INC. | — | — |
| 2453 | ILLUMINATE THERAPEUTICS, INC. | — | — |
| 2454 | TERAPORE TECHNOLOGIES, INC. | — | $3.5M |
| 2455 | Plexium | — | $60M |
| 2456 | Prolific Machines | — | $55M |
| 2457 | LIFESPLICE PHARMA, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Stuart BerkowitzDirector
- Rachel DorinDirector · Executive Officer
- Mark HurwitzDirector
- David MichaelDirector
- David SeldinDirector
Patents
- Chemically Resistant Isoporous Crosslinked Block Copolymer Structuregranted
- Isoporous Self-assembled Block Copolymer Films Containing High Molecular Weight Hydrophilic Additives And Methods Of Making The Samegranted
- Multi-layer Porous Block Copolymer Filmsapplication
- Charged Isoporous Materials For Electrostatic Separationsgranted
- Isoporous Mesoporous Asymmetric Block Copolymer Materials With Macrovoids And Method Of Making The Samegranted
- Chemically Resistant Fluorinated Multiblock Polymer Structures, Methods Of Manufacturing And Usegranted
- Ligand Bound Mbp Membranes, Uses And Method Of Manufacturinggranted
- Isoporous Self-assembled Block Copolymer Films Containing High Molecular Weight Hydrophilic Additives And Methods Of Making The Samegranted
- Charged Isoporous Materials For Electrostatic Separationsapplication
- Method Of Filtering Liquids Or Gases For Electronics Productionapplication
- Encapsulating Particle Fractionation Devices And Systems And Methods Of Their Useapplication
- Free Standing Pleatable Block Copolymer Materials And Method Of Making The Sameapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.